Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cempra’s New Drug Holds Potential, but Risk for Investors
Cempra’s New Drug Holds Potential, but Risk for Investors
Cempra’s New Drug Holds Potential, but Risk for Investors
Submitted by
admin
on October 30, 2015 - 11:14am
Source:
TheStreet.com
News Tags:
Cempra
Solithromycin
FDA
antibiotics
Headline:
Cempra’s New Drug Holds Potential, but Risk for Investors
Do Not Allow Advertisers to Use My Personal information
